组织蛋白酶L(CTSL)多克隆抗体
Polyclonal Antibody to Cathepsin L (CTSL)
CTSL1; CATL; CTS-L; MEP; Cathepsin L1; Major excreted protein
- 编号PAA306Mu01
- 物种Mus musculus (Mouse,小鼠) 相同的名称,不同的物种。
- 来源多抗制备
- 宿主兔
- 效价-
- Ig类型 IgG
- 纯化方式抗原特异性亲和纯化
- 标记物无标记物
- 免疫原 RPA306Mu01-组织蛋白酶L(CTSL)重组蛋白
- 缓冲液成份0.01M 磷酸盐缓冲液(pH7.4,containing 0.05% Proclin-300,50% glycerol)
- 性状液体
- 浓度1mg/ml
- 且适物种Rattus norvegicus (Rat,大鼠)
- 应用WB; IHC; ICC; IP.
如果抗体需用于流式细胞术,请参见流式抗体。 - 下载 英文说明书 中文说明书
- 规格 20µl100µl 200µl 1ml 10ml
- 价格 ¥ 583 ¥ 1361 ¥ 1944 ¥ 4860 ¥ 19440
- 欲了解实际交易价格和更多情况,请与当地经销商联系!
特异性
该抗体是针对CTSL的兔多克隆抗体。在免疫组织化学染色和免疫印迹实验中能识别CTSL。
用法
Western blotting: 0.5-2µg/mL;1:500-2000
Immunohistochemistry: 5-20µg/mL;1:50-200
Immunocytochemistry: 5-20µg/mL;1:50-200
Optimal working dilutions must be determined by end user.
储存
经常使用则4°C保存。-20°C保存不超过两年。避免反复冻融。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。
赠品
增值服务
相关产品
编号 | 适用物种:Mus musculus (Mouse,小鼠) | 应用(仅供研究使用,不用于临床诊断!) |
RPA306Mu01 | 组织蛋白酶L(CTSL)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA306Mu02 | 组织蛋白酶L(CTSL)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAA306Mu02 | 组织蛋白酶L(CTSL)多克隆抗体 | WB; IHC; ICC; IP. |
PAA306Mu01 | 组织蛋白酶L(CTSL)多克隆抗体 | WB; IHC; ICC; IP. |
LAA306Mu71 | 组织蛋白酶L(CTSL)多克隆抗体(生物素标记) | WB; IHC; ICC. |
SEA306Mu | 组织蛋白酶L(CTSL)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMA306Mu | 组织蛋白酶L(CTSL)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
参考文献
杂志 | 参考文献 |
Hypertension | Identification of Cathepsin L as a Potential Sex-Specific Biomarker for Renal Damage. [Ahajournals: source] |
The Journal of International Medical Research | Plasma Cathepsin L and Its Related Pro/Antiangiogenic Factors Play Useful Roles in Predicting Rich Coronary Collaterals in Patients with Coronary Heart Disease [Ingenta: art00021] |
Atherosclerosis.? | Biochemical and clinical correlation of intraplaque neovascularization using contrast-enhanced ultrasound of the carotid artery [Pubmed:24534452] |
International Journal of Molecular Sciences | A New Analytical Method for Determination of Cathepsin L Based on the Surface Plasmon Resonance Imaging Biosensor [Pubmed: 31052424] |
EMBO Molecular Medicine | Immune‐mediated ECM depletion improves tumour perfusion and payload delivery [Pubmed: 31709774] |
Cardiovasc Res | Inhibition of myocardial cathepsin-L release during reperfusion following myocardial infarction improves cardiac function and reduces infarct size [34132807] |
留言咨询